Related references
Note: Only part of the references are listed.Annual report to the nation on the status of cancer, part I: National cancer statistics
S. Jane Henley et al.
CANCER (2020)
Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers
S. Jane Henley et al.
CANCER (2020)
Patient Adherence to Screening for Lung Cancer in the US A Systematic Review and Meta-analysis
Maria A. Lopez-Olivo et al.
JAMA NETWORK OPEN (2020)
The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer
Kevin Jao et al.
LUNG CANCER (2018)
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
J. -C. Soria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clinicopathologic characteristics and survival outcome in patients with advanced lung adenocarcinoma and KRAS mutation
Shifeng Yang et al.
JOURNAL OF CANCER (2018)
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Leora Horn et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015
Ahmedin Jemal et al.
JAMA ONCOLOGY (2017)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Vital Signs: Disparities in Tobacco-Related Cancer Incidence and Mortality - United States, 2004-2013
S. Jane Henley et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial
Nanda Horeweg et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial
Ugo Pastorino et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2012)
Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round
N. Becker et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
Zaigham Saghir et al.
THORAX (2012)
Surgical Procedures in the DANTE Trial, A Randomized Study of Lung Cancer Early Detection with Spiral Computed Tomography Comparative Analysis in the Screening and Control Arm
Maurizio Infante et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT
Andrea Lopes Pegna et al.
LUNG CANCER (2009)
Annual Report to the Nation on the Status of Cancer, 1975-2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement Guidelines for Reporting Observational Studies
Erik von Elm et al.
EPIDEMIOLOGY (2007)
Share Paper
